26Jun
Financial Daily Dose 6.25.2019 | Top Story: Allergan and AbbVie Combine Forces in $63 Billion Deal
Massive pharma news to start the day, with AbbVie announcing that it’s reached a deal to buy Allergan for roughly $63 billion. The tie-up is seen as giving AbbVie a “dominant position in the $8 billion-plus market for Botox and other beauty drugs” is...
By:
Robins Kaplan LLP
Related
Financial institutions M&A sector trends: asset/wealth management — H2 2019 and outlook for 2020 - ...
Read More >
The outbreak of the coronavirus has been an unprecedented event affecting every industry, including ...
Read More >
A scathing USDOL Inspector General (IG) Report reveals Obama and Trump Administration OFCCP construc...
Read More >
Seyfarth Synopsis: Halloween was last week, and you probably thought all the scary ghouls and goblin...
Read More >
On October 29, 2019, the Seventh Circuit held that Burlington Northern Santa Fe Railway Company (“B...
Read More >
CONVERGE19 is in its 4th year of bringing together the world’s leading companies for 2 days of dyna...
Read More >